Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017-2022

CONCLUSIONS: Most GLP-1RA cases reported to US poison centers were associated with no or minimal effects and did not require referral for medical treatment; however, a notable minority of individuals experienced a serious medical outcome or healthcare facility admission. The rate of reported cases increased during the study period, including an 80.9% increase from 2021 to 2022. Opportunities exist to improve provider and patient awareness of the adverse effects of these medications.PMID:38421490 | DOI:10.1007/s13181-024-00999-x

Source: Journal of Medical Toxicology - February 29, 2024 Category: Toxicology Authors: Christopher E Gaw Hannah L Hays Cydney A Kemp Sandhya Kistamgari Henry A Spiller Natalie I Rine Allison L Rhodes Motao Zhu Gary A Smith Source Type: research